Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study
Charaka Hadinnapola, Mark Southwood, Jules Hernández‐Sánchez, Katherine Bunclark, Michael Newnham, Emilia M. Swietlik, John Cannon, Stephen Preston, Karen Sheares, Dolores Taboada, Nicholas Screaton, David P. Jenkins, Nicholas W. Morrell, Mark Toshner, Joanna Pepke‐Żaba
Topics & Concepts
MedicineInternal medicineBiomarkerThrombusCardiologyGastroenterologyPulmonary hypertensionAngiogenesisProportional hazards modelPulmonary embolismEndothelial activationChronic thromboembolic pulmonary hypertensionAngiopoietinEndothelial dysfunctionHemodynamicsInflammationVascular endothelial growth factorChemistryBiochemistryVEGF receptorsPulmonary Hypertension Research and TreatmentsAngiogenesis and VEGF in CancerPlatelet Disorders and Treatments